FDA Approves Iberdomide Plus Daratumumab and Dexamethasone for Multiple Myeloma (oncologynewscentral.com)
A new class of multiple myeloma treatment has arrived. The FDA has approved Zenbexus in combination therapy for previously treated patients, the first approved CELMoD protein degrader for multiple myeloma. www.oncologynewscentral.com/drugs/info/f...
